47.72
price up icon1.88%   0.88
after-market Dopo l'orario di chiusura: 47.72
loading

Q 32 Bio Inc Borsa (QTTB) Ultime notizie

pulisher
06:59 AM

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference - Kilgore News Herald

06:59 AM
pulisher
Nov 03, 2024

Brokerages Set Q32 Bio Inc. (NASDAQ:QTTB) Target Price at $72.33 - Defense World

Nov 03, 2024
pulisher
Oct 28, 2024

Q32 Bio (NASDAQ:QTTB) Shares Down 3.6%Time to Sell? - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ - GlobeNewswire

Oct 28, 2024
pulisher
Oct 28, 2024

Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight - India Shorts

Oct 28, 2024
pulisher
Oct 27, 2024

Q32 Bio (NASDAQ:QTTB) Stock Price Up 5% – Here’s Why - Defense World

Oct 27, 2024
pulisher
Oct 25, 2024

Q32 Bio (NASDAQ:QTTB) Stock Price Up 5%Here's What Happened - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

Raymond James Initiates Coverage of Q32 Bio (QTTB) with Strong Buy Recommendation - MSN

Oct 24, 2024
pulisher
Oct 24, 2024

Q32 Bio (NASDAQ:QTTB) Research Coverage Started at Raymond James - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Upstream Bio stock rallies 32% following upsized $255M IPO - MSN

Oct 24, 2024
pulisher
Oct 16, 2024

Oppenheimer Maintains Bullish Stance on Q32 Bio with Robust Clinical Outlook - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

Oppenheimer Maintains Bullish Stance on Q32 Bio with Robust Clin - GuruFocus.com

Oct 16, 2024
pulisher
Oct 16, 2024

ADX-097, potential AAV therapy, fares well in healthy volunteers - ANCA Vasculitis News

Oct 16, 2024
pulisher
Oct 16, 2024

Oppenheimer holds stock target, upbeat on Q32 Bio ahead of data - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Oppenheimer holds stock target, upbeat on Q32 Bio ahead of data By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 14, 2024

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 - cnhinews.com

Oct 14, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Buys 685,151 Shares of GlycoMimetics, Inc. (NASDAQ:GLYC) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Decreases Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Citizens Community Bancorp, Inc. (NASDAQ:CZWI) Shares Sold by Renaissance Technologies LLC - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Grows Stock Holdings in OptimumBank Holdings, Inc. (NASDAQ:OPHC) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Acquires Shares of 66,500 Waldencast plc (NASDAQ:WALD) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Takes $265,000 Position in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Buys Shares of 84,300 Metalla Royalty & Streaming Ltd. (NYSEMKT:MTA) - Defense World

Oct 13, 2024
pulisher
Oct 10, 2024

private equity firms who own 52% along with institutions invested in Q32 Bio Inc. (NASDAQ:QTTB) saw increase in their holdings value last week - Simply Wall St

Oct 10, 2024
pulisher
Oct 08, 2024

Q32 Bio (NASDAQ:QTTB) Shares Up 4.8% – What’s Next? - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Q32 Bio (NASDAQ:QTTB) Stock Price Up 4.8%What's Next? - MarketBeat

Oct 08, 2024
pulisher
Oct 06, 2024

Analysts Set Q32 Bio Inc. (NASDAQ:QTTB) PT at $68.80 - MarketBeat

Oct 06, 2024
pulisher
Oct 01, 2024

Q32 Bio Inc. Patent Woes: Navigating the Perilous Waters of Intellectual Property Disputes - TipRanks

Oct 01, 2024
pulisher
Sep 30, 2024

Q32 Bio's SWOT analysis: emerging biotech stock targets inflammatory diseases - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Q32 Bio's SWOT analysis: emerging biotech stock targets inflammatory diseases By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 29, 2024

Sherwin-Williams (SHW) Set to Announce Quarterly Earnings on Monday - Defense World

Sep 29, 2024
pulisher
Sep 29, 2024

Ensign Peak Advisors Inc Purchases 38,750 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Sep 29, 2024
pulisher
Sep 26, 2024

Bank of New York Mellon Corp Makes New $315,000 Investment in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Sep 26, 2024
pulisher
Sep 23, 2024

Bruce K. Posey Sells 1,330 Shares of Qualys, Inc. (NASDAQ:QLYS) Stock - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

QXO (NASDAQ:QXO) Trading Up 4.7% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Q32 Bio (NASDAQ:QTTB) Trading Down 3.7% - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Q32 Bio (NASDAQ:QTTB) Shares Down 3.7% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Stock Surge: Qualigen Therapeutics Inc (QLGN) Closes at 0.17, Marking a -4.84 Increase/Decrease - The Dwinnex

Sep 23, 2024
pulisher
Sep 22, 2024

Q32 Bio Inc.(NasdaqGM: QTTB) added to S&P Global BMI Index - Marketscreener.com

Sep 22, 2024
pulisher
Sep 22, 2024

Mutual of America Capital Management LLC Trims Stock Position in Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Client First Investment Management LLC Purchases New Stake in ProShares Ultra QQQ (NYSEARCA:QLD) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Davidson Capital Management Inc. Boosts Holdings in Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Inspire Investing LLC Acquires 2,595 Shares of Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Choreo LLC Makes New $264,000 Investment in Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Q32 Bio (NASDAQ:QTTB) Sees Strong Trading Volume - MarketBeat

Sep 19, 2024
pulisher
Sep 17, 2024

Q32 Bio (NASDAQ:QTTB) Trading 8.2% Higher - MarketBeat

Sep 17, 2024
pulisher
Sep 16, 2024

Harvard Management Co. Inc. Purchases New Stake in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Sep 16, 2024
pulisher
Sep 14, 2024

Q32 Bio Inc. (NASDAQ:QTTB) Receives $68.80 Average PT from Analysts - Defense World

Sep 14, 2024
pulisher
Sep 14, 2024

EchoStar (NASDAQ:SATS) Hits New 12-Month High Following Analyst Upgrade - Defense World

Sep 14, 2024
pulisher
Sep 12, 2024

Q32 Bio (NASDAQ:QTTB) Sets New 52-Week High at $52.64 - MarketBeat

Sep 12, 2024
pulisher
Sep 12, 2024

Wells Fargo & Company Begins Coverage on Q32 Bio (NASDAQ:QTTB) - MarketBeat

Sep 12, 2024
pulisher
Sep 11, 2024

Q32 Bio Inc. (NASDAQ:QTTB) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Sep 11, 2024
pulisher
Sep 11, 2024

Q32 Bio's Stock (NASDAQ:QTTB) Hits 52 Week High As Wells Fargo Initiates With Lofty Price Target - AskTraders

Sep 11, 2024
pulisher
Sep 10, 2024

QTTB stock soars to 52-week high, reaching $47.5 - Investing.com India

Sep 10, 2024
pulisher
Sep 07, 2024

10 Best Small Cap Stocks to Buy Now in 2024 - MarketBeat

Sep 07, 2024
pulisher
Sep 07, 2024

Q32 Bio (NASDAQ:QTTB) Shares Up 3.3% - MarketBeat

Sep 07, 2024
pulisher
Sep 05, 2024

Q32 Bio (NASDAQ:QTTB) Sets New 52-Week High at $45.00 - MarketBeat

Sep 05, 2024
pulisher
Sep 04, 2024

Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 91.69%: Read This Before Placing a Bet - Yahoo Finance UK

Sep 04, 2024
pulisher
Aug 30, 2024

Q32 Bio (NASDAQ:QTTB) Sets New 52-Week High at $43.48 - MarketBeat

Aug 30, 2024
pulisher
Aug 29, 2024

Q32 Bio to Participate in Upcoming September Investor Conferences - Elk Valley Times

Aug 29, 2024
pulisher
Aug 29, 2024

Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097 (NASDAQ:QTTB) - Seeking Alpha

Aug 29, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):